Avience Biomedicals (NSE:AVIENCE) NonCurrent Deferred Liabilities: ₹0.0 Mil (As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals NonCurrent Deferred Liabilities?

Avience Biomedicals NSE:AVIENCE 5 NonCurrent Deferred Liabilities is ₹0.0 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Avience Biomedicals's non-current deferred liabilities for the quarter that ended in Jan. 2026 was ₹0.0 Mil.

Avience Biomedicals NonCurrent Deferred Liabilities Related Terms

Avience Biomedicals NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals NonCurrent Deferred Liabilities Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
NonCurrent Deferred Liabilities
0.00 0.00 0.00

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
NonCurrent Deferred Liabilities 0.00 0.00 0.00 0.00
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of ₹0.0 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a NonCurrent Deferred Liabilities of ₹0.0 Mil as of Jan. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' NonCurrent Deferred Liabilities too high?
Avience Biomedicals' current NonCurrent Deferred Liabilities is ₹0.0 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' NonCurrent Deferred Liabilities compare to ABT and SYK?
Avience Biomedicals' NonCurrent Deferred Liabilities of ₹0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Devices & Instruments company?
A good NonCurrent Deferred Liabilities depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current NonCurrent Deferred Liabilities is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current NonCurrent Deferred Liabilities of ₹0.0 Mil. The current NonCurrent Deferred Liabilities is ₹0.0 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current NonCurrent Deferred Liabilities is ₹0.0 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price